182 related articles for article (PubMed ID: 7342850)
1. Reactivity of tumor-infiltrating, blood, spleen and lymph node lymphocytes against syngeneic glioma target cells.
Stavrou D; Bilzer T; Anzil AP; Hultén M; Kaldrymidou E
Anticancer Res; 1981; 1(3):125-34. PubMed ID: 7342850
[TBL] [Abstract][Full Text] [Related]
2. The influence of various chemicals on the surface structure and the antigenicity of syngeneic glioma cells.
Zänker KS; Stavrou D; Hultén M; Bilzer T
Anticancer Res; 1981; 1(2):101-7. PubMed ID: 7347153
[TBL] [Abstract][Full Text] [Related]
3. Phenotype and functional activity of tumor-infiltrating lymphocytes isolated from immunogenic and nonimmunogenic rat brain tumors.
Tzeng JJ; Barth RF; Orosz CG; James SM
Cancer Res; 1991 May; 51(9):2373-8. PubMed ID: 2015600
[TBL] [Abstract][Full Text] [Related]
4. The humoral antibody response of rats immunized with chemically modified syngeneic brain cells and glioma cells.
Stavrou D; Hultén M; Anzil AP; Bilzer T
Int J Cancer; 1980 Nov; 26(5):629-37. PubMed ID: 7239719
[TBL] [Abstract][Full Text] [Related]
5. [Effects of adult thymectomy on the growth of 203-glioma in mice--analysis of T cell subpopulation in tumor immunology].
Yamasaki T; Yamashita J; Handa H; Namba Y; Hanaoka M
No To Shinkei; 1982 Nov; 34(11):1067-75. PubMed ID: 6984337
[TBL] [Abstract][Full Text] [Related]
6. [Effects of TCGF (T-cell growth factor) on experimental malignant glioma-specific killer T-cell].
Yamasaki T; Yamashita J; Handa H; Namba Y; Hanaoka M
No Shinkei Geka; 1984 Feb; 12(2):141-50. PubMed ID: 6609319
[TBL] [Abstract][Full Text] [Related]
7. Chemical modification and antigenicity of glioma cells.
Stavrou D; Hultén M; Bilzer T
Acta Neuropathol Suppl; 1981; 7():75-8. PubMed ID: 6164240
[TBL] [Abstract][Full Text] [Related]
8. Natural killer (NK) cell activity in the rat. I. Isolation and characterization of the effector cells.
Reynolds CW; Timonen T; Herberman RB
J Immunol; 1981 Jul; 127(1):282-7. PubMed ID: 7240744
[TBL] [Abstract][Full Text] [Related]
9. Cell-mediated immune response in rats immunized with chemically modified syngeneic glioma cells. Monitoring by in vivo parameters and in vitro immune cytolysis.
Bilzer T; Stavrou D; Dahme E; Anzil AP
Anticancer Res; 1982; 2(6):345-54. PubMed ID: 6984814
[No Abstract] [Full Text] [Related]
10. Serologic analysis of nitrosourea-induced rat gliomas.
Pfreundschuh M; Cravioto H; Hochwald G; Ransohoff J
J Natl Cancer Inst; 1982 Mar; 68(3):501-5. PubMed ID: 6950179
[TBL] [Abstract][Full Text] [Related]
11. [Separation and functional analysis of tumor-infiltrating lymphocytes in brain tumor tissues].
Saito T; Tanaka R; Takai N; Hara N; Yoshida S
No To Shinkei; 1988 Dec; 40(12):1137-42. PubMed ID: 3266842
[TBL] [Abstract][Full Text] [Related]
12. Functional analysis of mononuclear cells infiltrating into tumors. II. Differential ability of mononuclear cells obtained from various tissues to produce helper factors that are involved in the generation of cytotoxic cells.
Uede T; Kohda H; Ibayashi Y; Osawa H; Diamantstein T; Kikuchi K
J Immunol; 1985 Nov; 135(5):3243-51. PubMed ID: 3900205
[TBL] [Abstract][Full Text] [Related]
13. Rat natural killer cell activity against lymphoid and nonlymphoid tumor cells and normal rat cell lines.
Rees RC; Reynolds CW; Herberman RB
Cancer Res; 1983 Sep; 43(9):4248-52. PubMed ID: 6871862
[TBL] [Abstract][Full Text] [Related]
14. Lymphoid cells infiltrating human pulmonary tumors: effect of intralesional BCG injection.
Niitsuma M; Golub SH; Edelstein R; Holmes EC
J Natl Cancer Inst; 1981 Nov; 67(5):997-1003. PubMed ID: 6457925
[TBL] [Abstract][Full Text] [Related]
15. [Cytotoxic natural anti-tumor antibodies against fibrosarcoma and glioma cells in rats (author's transl)].
Itaya T
Hokkaido Igaku Zasshi; 1981 Sep; 56(5):499-506. PubMed ID: 7319460
[TBL] [Abstract][Full Text] [Related]
16. Treatment of murine gliomas by adoptive transfer of ex vivo activated tumor-draining lymph node cells.
Plautz GE; Touhalisky JE; Shu S
Cell Immunol; 1997 Jun; 178(2):101-7. PubMed ID: 9225000
[TBL] [Abstract][Full Text] [Related]
17. Glioma-specific cytotoxic T cells can be effectively induced by subcutaneous vaccination of irradiated wild-type tumor cells without artificial cytokine production.
Iwadate Y; Yamaura A; Sakiyama S; Sato Y; Tagawa M
Int J Oncol; 2003 Aug; 23(2):483-8. PubMed ID: 12851699
[TBL] [Abstract][Full Text] [Related]
18. [Changes of natural killer activity following local 60Co irradiation in intracranial tumor-bearing mice (author's transl)].
Otsuka S; Suda K; Yamashita J; Takeuchi J; Handa H
No To Shinkei; 1982 Apr; 34(4):393-8. PubMed ID: 7093076
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic vaccination against malignant gliomas based on allorecognition and syngeneic tumor antigens: proof of principle in two strains of rat.
Stathopoulos A; Samuelson C; Milbouw G; Hermanne JP; Schijns VE; Chen TC
Vaccine; 2008 Mar; 26(14):1764-72. PubMed ID: 18336964
[TBL] [Abstract][Full Text] [Related]
20. Natural cytotoxicity in man: activity of lymph node and tumor-infiltrating lymphocytes.
Vose BM; Vánky F; Argov S; Klein E
Eur J Immunol; 1977 Nov; 7(11):353-7. PubMed ID: 304003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
